| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.004 |